Kebuzone: Difference between revisions
Appearance
Content deleted Content added
CarsonGell (talk | contribs) No edit summary |
m Fixing the location of periods / full stops |
||
Line 52: | Line 52: | ||
}} |
}} |
||
'''Kebuzone''' (or '''ketophenylbutazone''') is a [[nonsteroidal anti-inflammatory drug]] (NSAID)<ref name="AustriaCodex">{{cite book|title=Austria-Codex|at=Rheumesser 3 ml-Ampullen|publisher=Österreichischer Apothekerverlag|location=Vienna|year=2018|language=German}}</ref> that was used for the treatment of inflammatory conditions such as [[thrombophlebitis]] and [[Rheumatoid arthritis|rheumatoid arthritis]] (RA)<ref>{{Cite web|url=https://drugs.ncats.io/drug/4VD83UL6Y6|title=NCATS Inxight: Drugs — KEBUZONE|website=drugs.ncats.io|language=en|access-date=2019-02-27}}</ref> |
'''Kebuzone''' (or '''ketophenylbutazone''') is a [[nonsteroidal anti-inflammatory drug]] (NSAID)<ref name="AustriaCodex">{{cite book|title=Austria-Codex|at=Rheumesser 3 ml-Ampullen|publisher=Österreichischer Apothekerverlag|location=Vienna|year=2018|language=German}}</ref> that was used for the treatment of inflammatory conditions such as [[thrombophlebitis]] and [[Rheumatoid arthritis|rheumatoid arthritis]] (RA).<ref>{{Cite web|url=https://drugs.ncats.io/drug/4VD83UL6Y6|title=NCATS Inxight: Drugs — KEBUZONE|website=drugs.ncats.io|language=en|access-date=2019-02-27}}</ref> |
||
==References== |
==References== |
Revision as of 23:59, 15 April 2020
![]() | |
Clinical data | |
---|---|
Routes of administration | intramuscular |
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 70–100 hours |
Excretion | renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.011.560 |
Chemical and physical data | |
Formula | C19H18N2O3 |
Molar mass | 322.35782 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Kebuzone (or ketophenylbutazone) is a nonsteroidal anti-inflammatory drug (NSAID)[1] that was used for the treatment of inflammatory conditions such as thrombophlebitis and rheumatoid arthritis (RA).[2]
References
- ^ Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag. 2018. Rheumesser 3 ml-Ampullen.
- ^ "NCATS Inxight: Drugs — KEBUZONE". drugs.ncats.io. Retrieved 2019-02-27.